The abstract is read at the publisher; the summary is JClub's.
Nearly one-fifth of patients with dermatomyositis (18.8%) had clinically documented peripheral neuropathy, identified a median of 3 years after diagnosis in this single-center cohort.
- Why it matters: Peripheral neuropathy in dermatomyositis is poorly characterized, and clinicians lack clear estimates of how often it occurs and what clinical and electrophysiological patterns it follows.
- What they did: In a cohort of 640 dermatomyositis patients (2008–2025), investigators reviewed records to identify peripheral neuropathy using exam, nerve conduction study, or skin punch biopsy, excluding diabetes/prediabetes, deficiencies, infection, trauma, compression, radiculopathy, and neurotoxic medications.
- The result: Peripheral neuropathy was linked to classic dermatomyositis (62.5% vs 51.7%) and higher arthralgia (79.2% vs 18.2%) and Raynaud syndrome (55.8% vs 38.7%), while NCS showed axonal mixed sensory-motor polyneuropathy most often (94.9% axonal; 58.9% mixed).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.